Pluri Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Pluri Inc. (PLUR) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$1.41 million for the 9-month period ending 2017-03-31, per its 10-Q filed 2017-05-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-05-08
- Pluri Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$12.22M, a 302.13% decline year-over-year.
- Pluri Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $7.01M.
- Pluri Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was $3.79M.
- Pluri Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was $6.36M, a 122.25% increase year-over-year.
- Pluri Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $1.31M, a 93.91% decline from fiscal 2015.
- Pluri Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was $21.54M, a 986.08% increase from fiscal 2014.
- Pluri Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was $1.98M.
- Pluri Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$19.80M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$12.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-08 | -$5.21M derived: sum of 2 quarters · filed 2017-05-08 | -$1.41M 10-Q · filed 2017-05-08 | $4.95M derived: sum of 4 quarters · filed 2017-05-08 |
| 2016-12-31 | $7.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-08 | $10.81M 10-Q · filed 2017-02-08 | $17.17M derived: sum of 3 quarters · filed 2017-02-08 | $23.21M derived: sum of 4 quarters · filed 2017-05-08 |
| 2016-09-30 | $3.79M 10-Q · filed 2016-11-07 | $10.16M derived: sum of 2 quarters · filed 2016-11-07 | $16.20M derived: sum of 3 quarters · filed 2017-05-08 | $13.96M derived: sum of 4 quarters · filed 2017-05-08 |
| 2016-06-30 | $6.36M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-07 | $12.41M derived: sum of 2 quarters · filed 2017-05-08 | $10.17M derived: sum of 3 quarters · filed 2017-05-08 | $1.31M 10-K · filed 2016-09-07 |
| 2016-03-31 | $6.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-08 | $3.81M derived: sum of 2 quarters · filed 2017-05-08 | -$5.05M 10-Q · filed 2017-05-08 | -$2.19M derived: sum of 4 quarters · filed 2017-05-08 |
| 2015-12-31 | -$2.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-08 | -$11.10M 10-Q · filed 2017-02-08 | -$8.23M derived: sum of 3 quarters · filed 2017-02-08 | -$278.00K derived: sum of 4 quarters · filed 2017-02-08 |
| 2015-09-30 | -$8.86M 10-Q · filed 2016-11-07 | -$6.00M derived: sum of 2 quarters · filed 2016-11-07 | $1.96M derived: sum of 3 quarters · filed 2016-11-07 | $8.16M derived: sum of 4 quarters · filed 2016-11-07 |
| 2015-06-30 | $2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-07 | $10.82M derived: sum of 2 quarters · filed 2016-09-07 | $17.02M derived: sum of 3 quarters · filed 2016-09-07 | $21.54M 10-K · filed 2016-09-07 |
| 2015-03-31 | $7.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-09 | $14.16M derived: sum of 2 quarters · filed 2016-05-09 | $18.67M 10-Q · filed 2016-05-09 | $24.28M derived: sum of 4 quarters · filed 2016-09-07 |
| 2014-12-31 | $6.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-08 | $10.72M 10-Q · filed 2016-02-08 | $16.33M derived: sum of 3 quarters · filed 2016-09-07 | $10.16M derived: sum of 4 quarters · filed 2016-09-07 |
| 2014-09-30 | $4.52M 10-Q · filed 2015-11-05 | $10.12M derived: sum of 2 quarters · filed 2016-09-07 | $3.95M derived: sum of 3 quarters · filed 2016-09-07 | $2.32M derived: sum of 4 quarters · filed 2016-09-07 |
| 2014-06-30 | $5.61M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-07 | -$564.00K derived: sum of 2 quarters · filed 2016-09-07 | -$2.20M derived: sum of 3 quarters · filed 2016-09-07 | $1.98M 10-K · filed 2016-09-07 |
| 2014-03-31 | -$6.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | -$7.81M derived: sum of 2 quarters · filed 2015-05-06 | -$3.62M 10-Q · filed 2015-05-06 | -$17.76M derived: sum of 4 quarters · filed 2015-09-09 |
| 2013-12-31 | -$1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | $2.55M 10-Q · filed 2015-02-05 | -$11.59M derived: sum of 3 quarters · filed 2015-09-09 | -$2.36M derived: sum of 4 quarters · filed 2015-09-09 |
| 2013-09-30 | $4.18M 10-Q · filed 2014-11-06 | -$9.96M derived: sum of 2 quarters · filed 2015-09-09 | -$722.00K derived: sum of 3 quarters · filed 2015-09-09 | |
| 2013-06-30 | -$14.14M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-09 | -$4.90M derived: sum of 2 quarters · filed 2015-09-09 | -$19.80M 10-K · filed 2015-09-09 | |
| 2013-03-31 | $9.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-08 | -$5.66M 10-Q · filed 2014-05-08 | ||
| 2012-12-31 | -$14.89M 10-Q · filed 2014-02-05 | |||
| 2012-06-30 | -$30.80M 10-K · filed 2014-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |